Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_3
2
25%
Ph phase_1
1
13%
Ph phase_4
3
38%
Ph phase_2
2
25%

Phase Distribution

1

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(3)

Detailed Status

Completed4
Withdrawn2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 32 (25.0%)
Phase 43 (37.5%)

Trials by Status

completed450%
not_yet_recruiting113%
terminated113%
withdrawn225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8